Singapore-based healthcare provider Precious Medical Group has announced the launch of the Tunku Laksamana Johor Cancer Centre and Hospital, a landmark RM500 million development featuring state-of-the-art diagnostic and treatment facilities.
The project aims to elevate oncology capacity in and beyond Johor while strengthening collaboration across Malaysia's public and private healthcare systems.
The first phase of the project, the Tunku Laksamana Johor Cancer Centre, will be inaugurated on 5th December 2025. It will feature advanced diagnostic and treatment capabilities, including a PET-CT and radiotherapy centre. When fully completed, it will also house a nuclear medicine facility equipped with Malaysia's first cyclotron outside the Klang Valley, enabling on-site production of medical radioisotopes for cancer imaging and therapy. This development will enhance early detection, improve treatment availability, and reduce dependence on distant radioisotope supply chains.
Construction and operations are projected to generate around 1,000 direct and indirect jobs, contributing to workforce development and supporting the broader goals of the Johor–Singapore Special Economic Zone (JS-SEZ) to drive high-value healthcare services. Following the centre's launch, Precious Medical Group will proceed with the development of a 200-bed hospital on the same site to provide comprehensive inpatient oncology and integrated support services.
Strategically located at Larkin Sentral, a major transport hub within the JS-SEZ, the project is positioned to facilitate cross-border medical collaboration, talent mobility, and knowledge transfer—further strengthening the resilience, capacity, and international reputation of Malaysia'shealthcare system, which already attracts more than 1.5 million medical tourists annually.
